Navigation Links
Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
Date:3/21/2011

WELLESLEY HILLS, Mass., March 21, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc. d/b/a/ Source MDx ("Source MDx") announced that the foundational patents of Source MDx will be offered for sale on April 29, 2011.

Source MDx holds a broad-based, array of patents that cover technical aspects of RNA transcript measurement, concepts surrounding normal ranges in healthy human subjects ("normals") and statistical methods generating multi-gene models for the discrimination of normals versus disease.  Key patents comprise the foundation of Source MDx's intellectual property portfolio.  These include:

A.  Systems and Methods for Characterizing a Biological Condition or Agent using Precision Gene Expression (#6,692,916 issued 02.17.04)

B.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,940,439 issued 11.01.05)

C.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,964,850 pending)

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – jffinnjr@finnwarnkegayton or 781-27-8840.  They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm Finn, Warnke & Gayton LLP of Wellesley Hills, Massachusetts (www.finnwarnkegayton.com).  He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as Assignee for the Benefit of Creditors and Liquidating Agent for corporations.  He has been involved in a number of loan workouts and bankruptcy cases for thirty-six (36) years.  His most recent Assignments for the Benefit of Creditors in the biotech field include Spherics, Inc., ActivBioics, Inc. Prospect Therapeutics, Inc. and Epix Pharmaceuticals, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@finnwarnkegatyon.com


'/>"/>
SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland
2. MPR Launches Patient Advisor—A Drug and Health Information Resource for Consumers From the Trusted Source Healthcare Practitioners Rely On
3. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
4. Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014
5. American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies
6. American Scientific Resources Rebrands Non-Contact Thermometer for Mass Market Consumer Appeal
7. Merz Launches New Online Resource for Patients with Focal Dystonias
8. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
9. New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure
10. American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements
11. FDA Launches Website To Help Regulated Industries Save Time, Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):